trials, has not been utilized in treatment of bladder cancer. The purpose of this study was to measure the cell death effect of HAL/Blue light on patient-derived bladder cancer organoids.
INTRODUCTION AND OBJECTIVES: Patient-derived xenografts (PDX) and organoids are potential powerful tools for preclinical testing of novel therapeutics. However, the fidelity of these model systems to the human primary tumor needs to be established. We aim to establish and molecularly characterize a human bladder cancer PDX in vivo and in an organoid system derived from the PDX for preclinical studies.
METHODS: Two-mm3 bits of urothelial carcinoma originated from muscle invasive disease excised in cystectomy were implanted subcutaneously into male severe combined immunodeficient mice to establish PDXs. Established PDXs (CoCaB 1) were passaged subcutaneously in SCID mice and histopathology of each passage was compared with the originating tumor. Tumor size was measured weekly by caliper to determine the growth rate of PDXs from early (P1/P2) through late passage (P8/P9). Representative early and late passages were collected for organoid establishment. For both early and late passages, proliferation was assessed by Ki67 in PDXs and organoids, and cell cycle analysis and MTS assay specifically in organoids. RNA sequencing was performed to compare the fidelity of PDX and organoids vs. primary tumor.
RESULTS: Histologically, 16 of the 16 (100%) PDXs generated from early through late passage (1-2 tumors per passage) were similar to the original high-grade urothelial carcinoma. In vivo, the latency of PDX establishment decreased upon passage (9 weeks to take in early P1/2 vs. 2 weeks to take in late P8/9) and the growth rate increased upon passage. Concordantly, Ki67 proliferation index increased from 40% in P1 to 95% in P8 and was positively correlated with increasing passage (Spearman R¼0.804, p¼0.001). Similarly, in organoids, late passage demonstrated a shorter growth doubling time, higher Ki67 proliferation index, and faster progression through cell cycle. Transcriptional analysis showed that the PDX contained 81-92% human transcripts, whereas organoids contained >99% human transcripts.
CONCLUSIONS: Bladder cancer PDXs histologically represented the originating disease. PDX and organoid systems demonstrated concordant increase in proliferation upon serial passages, suggesting clonal selection may take place in this aggressive tumor type. Despite more mouse stromal content in PDX, PDX and organoid represent two independent model systems with highly similar biological responses that allow therapeutic studies.
INTRODUCTION AND OBJECTIVES: MiRNAs packed in exosomes (EV) can affect cell-cell communication in the tumor microenvironment and play a crucial role in tumorigenesis. Our aim is the identification of a specific exosomal miRNA expression pattern depending on the invasiveness of urinary bladder cancer (BC) cells. Furthermore we want to characterize their functional role in reprogramming normal bladder fibroblasts (BF).
METHODS: EVs were isolated from invasive (T24,253J-BV,J82), non-invasive (RT112,5637) BC cells and normal bladder cells (HCV29) by ultracentrifugation and were characterized by Western Blot analysis, Nano Particle Tracking Analysis and electron microscopy. Uptake of PKH26-labeled BC-EV by hTERT-immortalized fibroblasts (hTERT-FB) was shown by LSM. EV-mediated miRNA transfer between BC cells and hTERT-FB was analyzed by transfection of BC cells with cel-miR-39, co-cultivation with hTERT-FB and qPCR. Proliferation and migration of EV-treated normal BF were measured by BrdU assay and Boyden Chamber assay.
RESULTS: Electron microscopy images revealed the typical size (61-81 nm) and vesicular structure of EV. Isolated EV exhibited a high amount of exosomal markers (CD81, syntenin) and less presence of contamination marker calreticulin. EV of invasive BC cells are characterized by a specific miRNA signature of 15 miRNAs. Validation of 6 selected miRNAs confirms a significant different expression between both, invasive and non-invasive cells and their EV. miR-30a-3p could be confirmed by qPCR to be significantly deregulated exclusively in EVs of invasive cells compared to the non-invasive counterparts, but not in the Vol. 199, No. 4S, Supplement, Sunday, May 20, 2018 THE JOURNAL OF UROLOGY â e717
